Robert E. Landry, EVP Finance CFO: Regeneron Pharmaceuticals REGN Sell · Filed 23/03/29

Trade details

Type: Insider sale
Amount: $129,452.78
Shares · price: 157 sh · $824.54 a share
Held after: 32,196 sh
Stock: Regeneron Pharmaceuticals REGN
Person: Robert E. LandryEVP Finance CFO
Trade date: 23/03/28
Filed: 23/03/29
Days to filing: 1 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Regeneron Pharmaceuticals trades, last 26 weeks

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/26~23/04/27

Robert E. Landry's recent trades

Robert E. LandryDirector
Planned sale10b5-1 planCytokinetics
Planned sale10b5-1 plan
Cytokinetics
CYTK
$147.2K
2,000 sh
$147.2K
Filed 09/11
Traded 09/11
Robert E. LandryEVP Finance CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$188.2K
223 sh
$188.2K
Filed 23/08/25
Traded 23/08/23
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$200.6K
243 sh
$200.6K
Filed 23/03/29
Traded 23/03/28
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$149.1K
181 sh
$149.1K
Filed 23/03/29
Traded 23/03/28
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$116.6K
142 sh
$116.6K
Filed 23/03/29
Traded 23/03/28

Robert E. Landry, CFO — sold $129.5K of Regeneron Pharmaceuticals REGN · 0.5% of holdings · 10b5-1 plan | Whalegun